Incubator Stock Review Initiates Coverage on Vystar

Rhea-AI Summary

Vystar (OTCQB: VYST) announced that Internet and Incubator Stock Review initiated coverage on October 24, 2025, citing Vystar’s portfolio of four start-ups and development support for management, structuring and marketing.

Highlights include Vytex latex alternatives for medical and consumer uses, FDA-cleared RxAir 400 air purifier covering up to 800 sq ft, energy technologies at FEC, and a planned GoPaid.com tokenization portal with a full launch expected in Q4 2025 and a BETA imminent. The research firm emphasized tokenization’s potential to expand access to the collectibles and fine art market.

Worcester, MA, Oct. 24, 2025 (GLOBE NEWSWIRE) -- Vystar^® Corporation (OTCQB: VYST) Vystar announced today the Internet and Incubator Stock Review has initiated coverage.

"We followed the team at Vystar over the past decade, as they assembled a portfolio of best-of-breed start-ups and companies. Vystar's goal has been to provide each of the companies with development assistance (management, corporate structuring and marketing) to the extent they could generate revenues and achieve profitability on a standalone basis."

Vystar has four start-ups under its umbrella, with the most recent addition GoPaid.com exhibiting breakthrough potential.

• Vystar’s Vytex^™ is a rubber hydrocarbon material with the proteins and non-rubber components that cause allergies removed to create an ultra-pure latex and dry rubber with a more compact molecular network of greater durability and flexibility that is virtually odor free with a reduced risk of developing or triggering contact allergies. Vytex is ideal for applications such as medical devices, catheters, tubing, condoms and gloves. Other products include foam mattresses, toppers, pillows, cushions, balloons, adhesives, sports equipment, footwear, apparel and threads. It is compatible with several synthetic rubbers which also enables their synergistic and symbiotic usage. Vystar has partnered with Corrie MacColl Global for sustainable sourcing, market development, manufacturing, sales & distribution. Vytex pillows, matresses and toppers are available at Vytex.com.
  
  
• RxAir promotes a healthy lifestyle with its innovative, patented UV-C light air purification technology. Independently tested by EPA- and FDA-certified laboratories, RxAir has been proven to destroy greater than 99.97% of airborne bacteria and viruses, including the flu, H1N1, multiple Coronavirus strains, pneumonia, MRSA, strep, TB, measles and the common cold.
  
  RxAir 3000 model is well-known for its use in healthcare facilities and commercial businesses, RxAir was able to pivot its strategy to focus on its smaller, more consumer-friendly RxAir 400 model; highlighting how consumers can now get quality air filtration, traditionally found in operating rooms and surgical centers, in the comfort of their own homes – or their small business – providing a level of comfort much needed during these times.
  
  FDA-cleared as a Class II medical device, the RxAir 400 covers up to 800 square feet, offering 15 different fan speeds. Its patented ‘kill chamber’ is where the magic happens, forcing the air around 3 powerful UV-C tubes for an extended period of time, ensuring the wavelength dosage needed to maximize the inactivation of viruses and bacteria.

• FEC - Fluid Energy Conversion (FEC) has taken a position as a global green energy company with a multitude of new technologies. We have an array of patented and soon-to-be patented technology that is destined to change energy production and energy usage in many arenas. Our independent research and development has focused on product solutions that harness stable vortex effects, cavitation and other unique fluid flow phenomena to move energy application into new chapters. Our main thrust is currently in water but other applications such as those in combustion are already being positioned as key concepts in those fields. For over 50 years, FEC’s chief scientist has developed and patented many successful inventions, both nationally and internationally, involving fluid mechanics, fluidics, thermodynamics and related physics. His experience has created a revolutionary extension of fluidic science that has led to patented products that are cost effective to manufacture, simple to understand, and they deliver an outstanding performance. Most of our technology does not require complicated processes or sophisticated electronics, making us truly unique.
• GoPaid.com - serves three main functions. First, we tokenize real-world collectables that can be traded on the blockchain. The collection GOPAID holds backs the company’s crypto currency as a (RWA) real-world asset. Occasionally we deaccession memorabilia’s of our collection making them available for sale. Lastly, we allow select large holders of GOPAID’s crypto currency to borrow items from the collection to display at their home’s, office or events.

" The Internet Stock Review stated, "What excites us most is their GoPaid.com Token portal, which has been under development since 2022 and is expected to launch fully in the 4th quarter. A BETA launch is anticipated in the next few weeks.”

The company is seeking to connect Crypto and Tokenization to the $62 billion domestic collectables and fine art market. In our opinion the tokenization of this market is game changing. It will for the first time, enable millions of investors to participate in the ownership of items which on an individual basis, range into the $10's of millions and out of the reach of most investors. Secondarily will enable the owners of these assets, for the first time, to sell partial ownership of their collectable or art, creating a partial liquidity event"

It further stated, "As illustration, the report highlighted the cash purchase of Claude Monet's Haystack, which was originally purchased for $2.3 million in 1986 and recently sold for $110.7 million. Had the work of art been tokenized in 1986, 100's if not 1,000's of investors could have participated. Additionally, had the ownership been in token form, the owner could have conceivably sold stake bringing in $10 million, as example, rather than having had to sell the masterpiece in its entirety."

"We are excited to initiate coverage and look forward to reporting on their launch and expansion into the collectable and art tokenization sector, which is estimated (all assets - equities, bonds, real estate, private assets and other financial instruments) to reach $16 trillion by 2030.

Investors can download or review the report https://internetstockreview.com/initiating-coverage-on-vystar-vyst/

About the Incubator and Internet Stock Review.

Roland Rick Perry, Managing Director of Institutional Analyst Inc. (IA), has been publishing investment newsletters since 1995, when he founded the firm.

Over the years, they have launched a series of industry-specific newsletters, including:

• Internet Stock Review (launched in 1998)
• Biotech Stock Review (2002)
• Beverage Stock Review (2015)
• Psychedelic Stock Review (2021)

These newsletters focus on small-cap companies across sectors like biotech, psychedelics, blockchain, beverages, and more, often highlighting what IA considers “best of breed” opportunities.

Institutional Analyst Inc. (IA), an independent investment research and investor relations firm, as well as editor of nine industry-specific investment reviews. Roland began his career on the floor of the Chicago Board Options Exchange (CBOE) as a runner in 1974. He later worked for a number of well-respected investment banking firms such as Merrill Lynch, Paine Webber, AG Becker Paribas, and Drexel Burnham Lambert, prior to launching his own firm in 1995. Phone (310) 594-8062 - The easiest way to reach us is to shoot us a text message.

The editorial staff can be reached via text or email @ (310) 594-8062

Internet | Biotech Stock Review
Psychedelic Stock Review
Email - roland@institutionalanalyst.com

LinkedIn
SeekingAlpha
Harvest Exchange
Stock Twits
Twitter

About Vystar Corporation:

Based in Worcester, Mass., Vystar^® Corp. (OTCQB: VYST) is the owner of RxAir^® UV light air purification products that destroy harmful airborne viruses and pathogens, Vytex^® Natural Rubber Latex (NRL), Partner/Investor of GOPAID.COM and Fluid Energy Solutions. Vytex is a multi-patented, all-natural, raw material that contains significantly reduced levels of the proteins found in natural rubber latex for a stronger, more durable, yet environmentally safe, "green" and fully biodegradable product that can be used in a broad range of consumer and medical products. For more information, visit www.vystarcorp.com.

Forward-looking Statements: Investors are cautioned that certain statements contained in this document as well as some statements in periodic press releases and some oral statements of VYST officials are "Forward-Looking Statements" within the meaning of the Private Securities Litigation Reform Act of 1995 (the "Act"). Forward-looking statements include statements which are predictive in nature, which depend upon or refer to future events or conditions, which include words such as "believes," "anticipates," "intends," "plans," "expects," and similar expressions. In addition, any statements concerning future financial performance (including future revenues, earnings or growth rates), ongoing business strategies or prospects, and possible future VYST actions, product development and delivery, which may be provided by management, are also forward-looking statements as defined by the Act. Incubator Stock Review is paid by the company and outside third parties to create content and host and build websites over a 4-6 month period. Vystar does not edit or provide content, the author is independent. Vystar currently owns less than 10% GOPAID.com through a partnership agreement. Forward-looking statements involve known and unknown risks, uncertainties, and other factors which may cause the actual results, performance or achievements of the Company to materially differ from any future results, performance, or achievements expressed or implied by such forward-looking statements and to vary significantly from reporting period to reporting period. Although management believes that the assumptions made and expectations reflected in the forward-looking statements are reasonable, there is no assurance that the underlying assumptions will, in fact, prove to be correct or that actual future results will not be different from the expectations expressed in this report. These statements are not guarantees of future performance and VYST has no specific intention to update these statements. Investors should go to sec.gov website for Vystar’s various 10K, 10Q and other reports.

Follow us on social media and discount codes:

X formally Twitter: @ VystarCompany@ vytex

Contacts Vystar:

Media & Investors: Jamie Rotman, jrotman@vytex.com

Media, Investors or To Partner with Vystar, Company Phone Number: (508) 791-9114

FAQ

What did Internet and Incubator Stock Review announce about Vystar (VYST) on October 24, 2025?

They initiated coverage of Vystar (VYST) and highlighted its four start-ups, products and planned GoPaid.com token portal launch in Q4 2025.

When is Vystar's GoPaid.com token portal expected to launch and what is the timeline?

The firm expects a full launch in Q4 2025 with a BETA launch anticipated in the next few weeks from the October 24, 2025 announcement.

What are the key products Vystar (VYST) cited in the coverage that could affect revenue?

Key products mentioned are Vytex rubber materials for medical and consumer goods and the FDA-cleared RxAir 400 purifier covering up to 800 sq ft.

How does Vystar describe the market opportunity for GoPaid tokenization (VYST)?

Vystar and the analyst noted tokenization could open the $62 billion domestic collectibles and fine art market to many more investors.

Is the RxAir 400 mentioned in the Vystar (VYST) coverage FDA-cleared and what is its claimed efficacy?

Yes; the RxAir 400 is described as an FDA-cleared Class II medical device and the technology is reported to inactivate > 99.97% of tested airborne bacteria and viruses in independent labs.

Where can investors read the initiating coverage report on Vystar (VYST)?

The initiating coverage report is available for review at the analyst’s website as linked in the announcement.